title: Impaired lymphocyte reactivity measured by immune function testing in untransplanted patients with cirrhosis.
abstract: The immune function test is an integrated measure of total mitogen-inducible CD4(+) T cell metabolic activity in the peripheral blood, and it is used to guide the dosing of immunosuppressive medications after solid organ transplantation. Recently, low CD4(+) T cell metabolic activity due to pharmacologic immunosuppression has been linked to rapidly progressive cirrhosis in hepatitis C virus (HCV)-infected liver transplant recipients. We speculate that either cirrhosis or HCV might adversely affect the CD4(+) T cell reactivity even in the absence of immunosuppressive medications. We thus performed this assay on a cohort of untransplanted hepatology patients who were not taking immunomodulatory drugs. Low mitogen-stimulated CD4(+) T cell metabolic reactivity was more commonly seen in untransplanted patients with HCV cirrhosis or with cirrhosis due to other causes but not in control patients or in those with chronic HCV in the absence of cirrhosis. The lowest mean CD4(+) T cell reactivities were seen in patients with both cirrhosis and HCV. Caution should be exercised when immune function test results are used to guide immunomodulatory therapy in transplant recipients with suspected cirrhosis, as low immune function test results may be a consequence of hepatic cirrhosis or of pharmacologic immunosuppression.
authors: Mailman School of Public Health, Columbia University, New York, NY, USA.
authors: Russell M
authors: RM
authors: Yee
authors: Mandeep S
authors: MS
authors: Lehil
authors: Catherine
authors: C
authors: Rongey
authors: Hui
authors: H
authors: Shen
authors: Myrna L
authors: ML
authors: Cozen
authors: Alexander
authors: A
authors: Monto
authors: James C
authors: JC
authors: Ryan
mesh_terms: D000328:Adult; D000368:Aged; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology* / Q000378:metabolism; D015331:Cohort Studies; D005260:Female; D019698:Hepatitis C, Chronic / Q000150:complications*; D006801:Humans; D007108:Immune Tolerance; D008103:Liver Cirrhosis / Q000276:immunology*; D008297:Male; D008875:Middle Aged
references: Liver Transpl. 2009 Nov;15 Suppl 2:S35-41
references: 19876940
references: Hepatology. 2002 Jan;35(1):140-8
references: 11786970
references: Transplant Proc. 2006 Apr;38(3):918-20
references: 16647510
references: Immunity. 2007 Jan;26(1):117-29
references: 17239632
references: Nat Rev Gastroenterol Hepatol. 2010 Aug;7(8):425-36
references: 20585339
references: Liver Transpl. 2008 Sep;14(9):1313-22
references: 18756485
references: Hepatol Res. 2010 Feb;40(2):179-87
references: 20070404
references: J Hepatol. 2004 Nov;41(5):830-6
references: 15519657
references: Semin Liver Dis. 1997;17(4):297-310
references: 9408965
references: Curr Opin Immunol. 2008 Feb;20(1):68-74
references: 18068343
references: Semin Liver Dis. 2000;20(1):17-35
references: 10895429
references: Am J Transplant. 2006 Oct;6(10):2232-7
references: 16869798
references: WHO Chron. 1965 Jan;19:31-2
references: 14229438
references: Clin Diagn Lab Immunol. 2000 Mar;7(2):307-11
references: 10702511
references: Liver Transpl. 2010 Feb;16(2):155-62
references: 20104483
references: Nature. 2005 Aug 18;436(7053):939-45
references: 16107833
references: Transplantation. 2004 Jan 27;77(2):226-31
references: 14742986
references: Hepatology. 1986 Mar-Apr;6(2):252-62
references: 3007318
references: Minerva Gastroenterol Dietol. 2007 Mar;53(1):1-7
references: 17415341